In Depth 9 Oct 2024
Promising cure for COPD: Is a breakthrough treatment within reach?
Find out whether a promising cure for COPD is within reach, after recent advancements in treatments and research around the disease.
Clinical trial
- Latest Posts
In Depth 7 Oct 2024
Spinal cord injury: Are we getting closer to a treatment?
Delve into the spinal cord injury treatment landscape with a few pharmaceutical approaches that could tackle this complex condition.
Best in Biotech 3 Oct 2024
Six biotechs driving progress in Duchenne muscular dystrophy
In this article, we take a look at six clinical-stage biotechs that are fostering R&D in the Duchenne muscular dystrophy therapeutic space.
In Depth 26 Sep 2024
The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond
Delve into the world of radiopharmaceuticals: explore their mechanisms, promising candidates, and the key players driving innovation.
In Depth 20 Sep 2024
Mitigating hot flashes: new therapies for menopause on the rise
New therapies could address menopause symptoms, a field in which many treatment gaps still exist.
In Depth 19 Sep 2024
Mitochondrial disease treatments: is a breakthrough on the horizon?
Mitochondrial dysfunction is linked to many diseases. Discover how biotechs are developing mitochondrial disease treatments to address these diseases.
ADVERTISEMENT
ADVERTISEMENT
Accelerating the path to clinical filing applications with rapid toxicology material delivery
Pre-clinical toxicology studies and prompt material delivery are essential for IND and CTA approvals, crucial for advancing drug candidates to clinical trials.
Best in Biotech 5 Sep 2024
Six biotech companies that could revolutionize obesity treatments
In this article, we take a look at six biotechs focused on bringing drugs to treat obesity to the market.
News and Trends 4 Sep 2024
2024: a year of breakthroughs for endometrial cancer?
New treatments have been approved by regulators for endometrial cancer, which are regarded as major therapeutic breakthroughs.
Navigating your path to globalization: Untangling the regulatory maze of the Advanced Therapies supply chain
Discover how Cryoport Systems can help you navigate EMEA regulations and manage the supply chain complexities for advanced therapies.
News and Trends 27 Aug 2024
Could microbiome drugs be the key to unlocking checkpoint inhibitors’ potential?
As Microbiotica announces phase 1 approval for two microbiome drugs we delve into their potential in oncology and beyond.
News and Trends 20 Aug 2024
Fighting mpox: promising vaccines to watch
As Bavarian Nordic ramps up production of the only marketed mpox vaccine, a few clinical trials are underway to combat the outbreak.
ADVERTISEMENT
